IL166313A0 - Indoline derivatives and pharmaceutical compositions containing the same - Google Patents

Indoline derivatives and pharmaceutical compositions containing the same

Info

Publication number
IL166313A0
IL166313A0 IL16631303A IL16631303A IL166313A0 IL 166313 A0 IL166313 A0 IL 166313A0 IL 16631303 A IL16631303 A IL 16631303A IL 16631303 A IL16631303 A IL 16631303A IL 166313 A0 IL166313 A0 IL 166313A0
Authority
IL
Israel
Prior art keywords
same
pharmaceutical compositions
compositions containing
indoline derivatives
pharmaceutically acceptable
Prior art date
Application number
IL16631303A
Other languages
English (en)
Original Assignee
Kyoto Pharma Ind
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyoto Pharma Ind filed Critical Kyoto Pharma Ind
Publication of IL166313A0 publication Critical patent/IL166313A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/08Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404Indoles, e.g. pindolol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/12Radicals substituted by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44Iso-indoles; Hydrogenated iso-indoles
    • C07D209/48Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
IL16631303A 2002-07-17 2003-07-16 Indoline derivatives and pharmaceutical compositions containing the same IL166313A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2002208878 2002-07-17
PCT/JP2003/009012 WO2004007450A1 (ja) 2002-07-17 2003-07-16 新規インドリン化合物およびその医薬用途

Publications (1)

Publication Number Publication Date
IL166313A0 true IL166313A0 (en) 2006-01-15

Family

ID=30112861

Family Applications (1)

Application Number Title Priority Date Filing Date
IL16631303A IL166313A0 (en) 2002-07-17 2003-07-16 Indoline derivatives and pharmaceutical compositions containing the same

Country Status (22)

Country Link
US (1) US7429612B2 (pl)
EP (1) EP1541553B1 (pl)
JP (1) JP4485357B2 (pl)
CN (1) CN100349868C (pl)
AT (1) ATE469884T1 (pl)
AU (1) AU2003252638B8 (pl)
BR (1) BR0312734A (pl)
CA (1) CA2492669A1 (pl)
CO (1) CO5690574A2 (pl)
DE (1) DE60332851D1 (pl)
DK (1) DK1541553T3 (pl)
HK (1) HK1083839A1 (pl)
IL (1) IL166313A0 (pl)
MX (1) MXPA05000749A (pl)
NO (1) NO20050834L (pl)
NZ (1) NZ538226A (pl)
PL (1) PL374919A1 (pl)
RS (1) RS20050127A (pl)
RU (1) RU2318808C2 (pl)
TW (1) TWI285196B (pl)
WO (1) WO2004007450A1 (pl)
ZA (1) ZA200501297B (pl)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102011076931A1 (de) 2011-06-03 2012-12-06 Basf Se Wässrige Lösung, enthaltend Acrylsäure und deren konjugierte Base
JP2018052818A (ja) * 2015-01-28 2018-04-05 武田薬品工業株式会社 スルホンアミド化合物

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4013404A (en) * 1970-12-06 1977-03-22 American Cyanamid Company Method of dyeing hair with indolines, indoles and indazoles
CH644116A5 (de) * 1980-08-21 1984-07-13 Hoffmann La Roche Imidazolderivate.
US4803218A (en) 1982-09-29 1989-02-07 Mcneilab, Inc. 3-aminoalkyl-1H-indole-5-urea and amide derivatives
US4956372A (en) 1987-10-02 1990-09-11 Kyorin Pharmaceutical Co., Ltd. Cyclic anthranilic acid derivatives and process for their preparation
JPH02117651A (ja) 1988-01-20 1990-05-02 Yamanouchi Pharmaceut Co Ltd ジウレア誘導体及びその製造法
US5166429A (en) 1988-01-20 1992-11-24 Yamanouchi Pharmaceutical Co., Ltd. Diurea derivatives useful as medicaments and processes for the preparation thereof
US5227492A (en) 1988-01-20 1993-07-13 Yamanouchi Pharmaceutical Co., Ltd. Diurea derivatives useful as medicaments and processes for the preparation thereof
CN1021819C (zh) 1988-01-20 1993-08-18 山之内制药株式会社 作为药物有用的双脲衍生物的制备方法
IE892088L (en) 1988-07-12 1990-01-12 William Henry Deryk Morris Quinoline derivatives, their production and use
JPH0753714B2 (ja) 1988-07-12 1995-06-07 武田薬品工業株式会社 Acat阻害剤、キノリン誘導体及びその製造法
US5153226A (en) 1989-08-31 1992-10-06 Warner-Lambert Company Acat inhibitors for treating hypocholesterolemia
DE69105786T2 (de) 1990-03-12 1995-04-27 Yamanouchi Pharma Co Ltd Harnstoffderivate, deren Herstellung sowie diese enthaltende pharmazeutische Zusammensetzungen.
US5258405A (en) 1990-03-12 1993-11-02 Yamanouchi Pharmaceutical Co., Ltd. Urea derivatives and salts thereof in method for inhibiting the ACAT enzyme
JPH0466568A (ja) 1990-06-29 1992-03-02 Takeda Chem Ind Ltd 中枢性抗酸化剤化合物
US5256782A (en) 1990-08-17 1993-10-26 Takeda Chemical Industries, Ltd. Thienopyridine derivatives which are intermediates
JP3086295B2 (ja) 1990-08-17 2000-09-11 武田薬品工業株式会社 チエノピリジン誘導体、その製造法およびacat阻害剤
US5143919A (en) 1990-08-17 1992-09-01 Takeda Chemical Industries, Ltd. Thienopyridine derivatives and their pharmaceutical use
FR2673625B1 (fr) 1991-03-08 1993-05-07 Adir Nouveaux derives d'acylaminophenol, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
FR2674522B1 (fr) 1991-03-26 1993-07-16 Lipha Nouveaux derives de l'indole, procedes de preparation et medicaments les contenant.
IL101785A0 (en) 1991-05-10 1992-12-30 Fujisawa Pharmaceutical Co Urea derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
CA2121391A1 (en) 1993-04-28 1994-10-29 Atsuyuki Kojima Indoloylguanidine derivatives
US6169107B1 (en) 1993-04-28 2001-01-02 Sumitomo Pharmaceutical Co., Ltd. Indoloylguanidine derivatives
JP3720395B2 (ja) * 1994-09-20 2005-11-24 京都薬品工業株式会社 新規ヘテロ環誘導体、その製造方法およびその医薬用途
JPH08208602A (ja) 1994-10-18 1996-08-13 Sumitomo Pharmaceut Co Ltd インドロイルグアニジン誘導体
CA2160600A1 (en) 1994-10-18 1996-04-19 Masahumi Kitano Indoloylguanidine derivatives
US5767129A (en) 1995-08-24 1998-06-16 Warner-Lambert Company Substituted quinolines and isoquinolines as calcium channel blockers, their preparation and the use thereof
IL123939A (en) * 1995-10-05 2001-11-25 Kyoto Pharma Ind The history of the heterocycles and the pharmaceutical preparations containing them
DE69702725T2 (de) 1996-03-04 2000-12-07 Fuji Photo Film Co., Ltd. Verarbeitungszusammensetzung für lichtempfindliches photographisches Silberhalogenidmaterial, Entwickler und Verarbeitungsverfahren unter dessen Verwendung
JP2002047269A (ja) * 2000-08-01 2002-02-12 Kyoto Pharmaceutical Industries Ltd ヘテロ環化合物の製造方法およびその中間体
JP2002302481A (ja) * 2001-02-02 2002-10-18 Sankyo Co Ltd インドリン誘導体と製造法
US20060264496A1 (en) * 2003-04-25 2006-11-23 H. Lundbeck A/S Substituted indoline and indole derivatives

Also Published As

Publication number Publication date
US20060128787A1 (en) 2006-06-15
AU2003252638B2 (en) 2009-02-05
TW200407304A (en) 2004-05-16
US7429612B2 (en) 2008-09-30
EP1541553B1 (en) 2010-06-02
JPWO2004007450A1 (ja) 2005-11-10
EP1541553A4 (en) 2007-04-11
WO2004007450A1 (ja) 2004-01-22
JP4485357B2 (ja) 2010-06-23
RU2005104238A (ru) 2005-08-27
ZA200501297B (en) 2006-10-25
AU2003252638B8 (en) 2009-03-05
NO20050834L (no) 2005-04-15
AU2003252638A1 (en) 2004-02-02
CN100349868C (zh) 2007-11-21
BR0312734A (pt) 2005-04-26
DK1541553T3 (da) 2010-09-20
CO5690574A2 (es) 2006-10-31
PL374919A1 (pl) 2005-11-14
NZ538226A (en) 2006-08-31
DE60332851D1 (de) 2010-07-15
TWI285196B (en) 2007-08-11
CA2492669A1 (en) 2004-01-22
RU2318808C2 (ru) 2008-03-10
MXPA05000749A (es) 2005-04-28
EP1541553A1 (en) 2005-06-15
CN1681781A (zh) 2005-10-12
ATE469884T1 (de) 2010-06-15
RS20050127A (en) 2007-06-04
HK1083839A1 (en) 2006-07-14

Similar Documents

Publication Publication Date Title
RS51444B (sr) JEDINJENJA KOJA SADRŽE LAKTAM I NJIHOVI DERIVATI KAO INHIBITORI FAKTORA Xa
WO2003006425A3 (en) Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents
DE602004008098D1 (de) Substituierte 2h-ä1,2,4ütriazoloä4,3-aüpyrazine als gsk-3-inhibitoren
ATE272633T1 (de) Aromatische amiden
MXPA04004674A (es) Ligados de los receptors de los canabinodies.
SE0302760D0 (sv) New compounds
AU2001280438A1 (en) Substituted heterocyclic amides
NO20054787D0 (no) Indenderivater som farmasotiske midler
IL173810A0 (en) Imidazopyridine derivatives and pharmaceutical compositions containing the same
AP1787A (en) Novel perindopril salt and pharmaceutical compositions containing same.
AU2003228674A1 (en) Muscarinic antagonists
NO20040881L (no) Orale antidiabetes midler.
AU2003250471A1 (en) Pyrimidine-2,4-dione derivatives as matrix metalloproteinase inhibitors
MXPA05011176A (es) Derivados de carboxamida como agentes antidiabeticos.
MXPA04006041A (es) Antivirales de piridoquinoxalina.
AU2003223340A1 (en) Certain pharmaceutically useful substituted aminoalkyl heterocycles
IL173895A0 (en) Imidazopyridine derivatives and pharmaceutical compositions containing the same
DE60114640D1 (en) Antithrombosemittel
MXPA05006889A (es) Compuestos aromaticos como agentes anti-inflamatorios, inmunomoduladores y anti-proliferativos.
GB0212410D0 (en) Organic compounds
AU2002248531A1 (en) Pyrazolopyriadine derivatives
WO2003080631A3 (en) Plasma carboxypeptidase b inhibitors
WO2004048381A3 (en) Pyrazoloazepine compounds as pharmaceutical agents
AU2002357740A1 (en) Pyrazolo-pyridine derivatives as antiherpes agents
HK1083839A1 (en) Indoline compound and medicinal use thereof